High Tide Inc.
HITI
NASDAQ·Healthcare·Medical - Pharmaceuticals·Mkt cap $217.9M
$2.48
▼ -1.20%
P/E
-6.26
Mkt Cap
$217.9M
52-Wk Range
$2.02–$4.06
52-Week Range
$2.02 - $4.06
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 25.5% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Largest private cannabis retailer network in Canada with 139+ locations
- Vertically integrated supply chain controlling manufacturing and distribution
- Established digital platforms with global reach and brand recognition
- Data analytics capabilities providing consumer insights and operational efficiency
Bear Case
2 risks
- Average volatility.
- Extreme premium - high expectations embedded
Growth
Turning profitable
Cannabis market legalization expansion across new jurisdictions in North America and Europe
Value
Extreme premium - high expectations embedded
Momentum
Stable
+2.1% over 3m
Quality
Thin
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying HITI right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Sep 14, 2026
JUN 15, 2026
Reported EPS of $0.01 vs -$0.02 consensus (+150.0% surprise). Revenue of $131.9M vs $125.9M expected (+4.8%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q2 26
+150.0%
Revenue trend · last 8Q
—
—
—
—
+11%
+14%
+19%
+25%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$91.4M
$96.8M
$101.7M
$104.8M
$101.3M
$110.1M
$120.6M
$131.3M
Margins · last 8Q
Gross
8.4%
Operating
2.3%
Profit
0.7%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Canaccord · Mar 19, 2026
vs Industry
How HITI stacks vs Medical - Pharmaceuticals
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related